(Q39056066)

8 September 2017

title

BTG1 expression correlates with the pathogenesis and progression of breast carcinomas (English)

1 reference

8 September 2017

S H Sheng

1

1 reference

8 September 2017

C M Zhao

series ordinal

2

1 reference

8 September 2017

G G Sun

series ordinal

3

1 reference

8 September 2017

publication date

24 November 2013

1 reference

8 September 2017

1 reference

8 September 2017

volume

35

1 reference

8 September 2017

issue

4

1 reference

8 September 2017

page(s)

3317-3326

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-013-1437-0

8 September 2017

exact match

0 references

cites work

The mammalian anti-proliferative BTG/Tob protein family

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1437-0

In search of a function for the TIS21/PC3/BTG1/TOB family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1437-0

Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1437-0

Signatures of tumor-immune interactions as biomarkers for breast cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1437-0

Mitochondrial biogenesis drives tumor cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1437-0

Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1437-0

Overexpression of cyclin E and cyclin-dependent kinase inhibitor (p27Kip1): effect on cell cycle regulation in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1437-0

Apoptosis. Life and death decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1437-0

The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1437-0

Role of antiproliferative B cell translocation gene-1 as an apoptotic sensitizer in activation-induced cell death of brain microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1437-0

Prognostic value of bcl-2 expression among women with breast cancer in Libya

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1437-0

High levels of bcl-2 protein expression do not correlate with genetic abnormalities but predict worse prognosis in patients with lymphoblastic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1437-0

Stromal effects on mammary gland development and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1437-0

Nuclear factor-kappa B and cancer: its role in prevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1437-0

BTG gene expression in the p53-dependent and -independent cellular response to DNA damage

21 January 2018

1 reference

12 December 2020

BTG1, a member of a new family of antiproliferative genes

1 reference

12 December 2020

B cell translocation gene 1 contributes to antisense Bcl-2-mediated apoptosis in breast cancer cells

1 reference

12 December 2020

BTG1 inhibits breast cancer cell growth through induction of cell cycle arrest and apoptosis

1 reference

12 December 2020

Combined evaluation of expressions of p53 and p21 proteins as prognostic factors for patients with gastric carcinoma

1 reference

12 December 2020

Antiproliferative gene BTG1 is highly expressed in apoptotic cells in macrophage-rich areas of advanced lesions in Watanabe heritable hyperlipidemic rabbit and human

1 reference

12 December 2020

10.1007/S13277-013-1437-0

Identifiers

DOI

1 reference

8 September 2017

1 reference